267 related articles for article (PubMed ID: 30938461)
1. Simultaneous occurrence of cutaneous and mucocutaneous leishmaniasis caused by different genotypes of Leishmania (Viannia) braziliensis.
Hoyos CL; Quipildor M; Bracamonte E; Lauthier JJ; Cajal P; Uncos A; Korenaga M; Hashiguchi Y; Barroso PA; Marco JD
J Dermatol; 2019 Sep; 46(9):e320-e322. PubMed ID: 30938461
[No Abstract] [Full Text] [Related]
2. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.
Pimentel MI; Baptista C; Rubin EF; Vasconcellos Ede C; Lyra MR; Salgueiro Mde M; Saheki MN; Rosalino CM; Madeira Mde F; Silva AF; Confort EM; Schubach Ade O
Rev Soc Bras Med Trop; 2011; 44(2):254-6. PubMed ID: 21552747
[TBL] [Abstract][Full Text] [Related]
3. Genotypic profiles of Leishmania (Viannia) braziliensis strains from cutaneous leishmaniasis patients and their relationship with the response to meglumine antimoniate treatment: a pilot study.
Gagini T; de Oliveira Schubach A; de Fatima Madeira M; Maria Valete-Rosalino C; Fernandes Pimentel MI; da Silva Pacheco R
Parasite; 2017; 24():34. PubMed ID: 28959938
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment by adding thalidomide to meglumine antimoniate in a case of refractory anthroponotic mucocutaneous leishmaniasis.
Goyonlo VM; Vahabi-Amlashi S; Taghavi F
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():177-179. PubMed ID: 31492621
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Unusual Presentation of Pharyngeal Mucosal Leishmaniasis due to
Figueiredo LP; Almeida LDC; Magalhães A; Arruda S; Lessa MM; Carvalho EM
Am J Trop Med Hyg; 2020 Oct; 103(4):1493-1495. PubMed ID: 32748768
[TBL] [Abstract][Full Text] [Related]
6. Parasitological diagnosis of mucocutaneous leishmaniasis due to Leishmania b. braziliensis in Bolivia.
Dimier-David L; David C; Ravisse P; Bustillos R; Revollo S; Lyèvre P; Muñoz M; Vargas F; Dedet JP
Rev Soc Bras Med Trop; 1991; 24(4):231-4. PubMed ID: 1845007
[TBL] [Abstract][Full Text] [Related]
7. First case of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis in Suriname.
Hu RV; Kent AD; Adams ER; van der Veer C; Sabajo LO; Mans DR; de Vries HJ; Schallig HD; Lai A Fat RF
Am J Trop Med Hyg; 2012 May; 86(5):825-7. PubMed ID: 22556081
[TBL] [Abstract][Full Text] [Related]
8. Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid.
Motta AC; Arruda D; Souza CS; Foss NT
Int J Dermatol; 2003 Sep; 42(9):703-6. PubMed ID: 12956682
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous leishmaniasis with secondary mucosal disease in a traveller due to Leishmania (Viannia) braziliensis.
Crone CG; Helleberg M
J Travel Med; 2020 Feb; 27(1):. PubMed ID: 31776570
[No Abstract] [Full Text] [Related]
10. American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short-term possibilities for an alternative treatment.
Carvalho SH; Frézard F; Pereira NP; Moura AS; Ramos LMQC; Carvalho GB; Rocha MOC
Trop Med Int Health; 2019 Apr; 24(4):380-391. PubMed ID: 30681239
[TBL] [Abstract][Full Text] [Related]
11. Mucosal leishmaniasis due to Leishmania (Viannia) braziliensis L(V)b in Três Braços, Bahia-Brazil.
Marsden PD
Rev Soc Bras Med Trop; 1994; 27(2):93-101. PubMed ID: 8073158
[TBL] [Abstract][Full Text] [Related]
12. [Aminosidine in the treatment of mucocutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis].
Romero GA; Lessa HA; Macêdo V; de Carvalho EM; de Magalhães AV; Orge M de la G; de Abreu MV; Marsden PD
Rev Soc Bras Med Trop; 1996; 29(2):215-6. PubMed ID: 8713613
[No Abstract] [Full Text] [Related]
13. Disseminated cutaneous leishmaniasis caused by Leishmania braziliensis in Southern Brazil.
Membrive NA; Kazuma FJ; Silveira TGV; Teixeira JJV; Reinhold-Castro KR; Teodoro U
Rev Inst Med Trop Sao Paulo; 2017 Jun; 59():e37. PubMed ID: 28591265
[TBL] [Abstract][Full Text] [Related]
14. Intralesional Antimonial Drug Treatment for Leishmania braziliensis Cutaneous Leishmaniasis: The Knowns and the Unknowns.
Aronson NE; Billick K
Clin Infect Dis; 2023 Aug; 77(4):583-588. PubMed ID: 37185765
[No Abstract] [Full Text] [Related]
15. Clinical characteristics of human Leishmania braziliensis braziliensis infections.
Llanos Cuentas EA; Cuba CC; Barreto AC; Marsden PD
Trans R Soc Trop Med Hyg; 1984; 78(6):845-6. PubMed ID: 6533860
[No Abstract] [Full Text] [Related]
16. Visceral leishmaniasis with cutaneous and rectal dissemination due to Leishmania braziliensis in acquired immunodeficiency syndrome (AIDS).
Hernández DE; Oliver M; Martínez C; Planas G
Int J Dermatol; 1995 Feb; 34(2):114-5. PubMed ID: 7737768
[No Abstract] [Full Text] [Related]
17. The migrant crisis comes to Minnesota: a dermatologist's perspective.
Knapp AP
Int J Dermatol; 2017 Dec; 56(12):1455-1456. PubMed ID: 29052222
[No Abstract] [Full Text] [Related]
18. Distribution, treatment outcome and genetic diversity of Leishmania species in military personnel from Colombia with cutaneous leishmaniasis.
Correa-Cárdenas CA; Pérez J; Patino LH; Ramírez JD; Duque MC; Romero Y; Cantillo-Barraza O; Rodríguez O; Alvarado MT; Cruz C; Méndez C
BMC Infect Dis; 2020 Dec; 20(1):938. PubMed ID: 33297972
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients.
Silva SC; Guimarães LH; Silva JA; Magalhães V; Medina L; Queiroz A; Machado PRL; Schriefer A
Acta Trop; 2018 Feb; 178():34-39. PubMed ID: 29042262
[TBL] [Abstract][Full Text] [Related]
20. Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate.
Basile G; Cristofaro G; Locatello LG; Vellere I; Piccica M; Bresci S; Maggiore G; Gallo O; Novelli A; Di Muccio T; Gramiccia M; Gradoni L; Gaiera G; Bartoloni A; Zammarchi L
Int J Infect Dis; 2020 Aug; 97():204-207. PubMed ID: 32505874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
